These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19680676)

  • 1. Avastin use in high risk corneal transplantation.
    Vassileva PI; Hergeldzhieva TG
    Graefes Arch Clin Exp Ophthalmol; 2009 Dec; 247(12):1701-6. PubMed ID: 19680676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined scraping, coagulation, and subconjunctival bevacizumab in Descemet stripping automated endothelial keratoplasty for bullous keratopathy.
    Chiang CC; Lin JM; Tsai YY
    Eur J Ophthalmol; 2013; 23(3):309-15. PubMed ID: 23161181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization.
    Agarwal S; Angayarkanni N; Iyer G; Srinivasan B; Natarajan R; Charola S; Arumugam S; Padmanabhan P
    Cornea; 2014 Oct; 33(10):1016-21. PubMed ID: 25090164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perilimbal bevacizumab injection for interface neovascularization after deep anterior lamellar keratoplasty.
    Foroutan A; Fariba B; Pejman B; Mahmoud J; Khalil GF; Arash EA; Foroutan P
    Cornea; 2010 Nov; 29(11):1268-72. PubMed ID: 20802316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy.
    Oh JY; Kim MK; Wee WR
    Cornea; 2009 Oct; 28(9):1070-3. PubMed ID: 19724199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subconjunctival bevacizumab for vascularized rejected corneal grafts.
    Awadein A
    J Cataract Refract Surg; 2007 Nov; 33(11):1991-3. PubMed ID: 17964413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subconjunctival and/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival.
    Fasciani R; Mosca L; Giannico MI; Ambrogio SA; Balestrazzi E
    Int Ophthalmol; 2015 Apr; 35(2):221-7. PubMed ID: 24715230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subconjunctival bevacizumab for corneal neovascularization.
    Erdurmus M; Totan Y
    Graefes Arch Clin Exp Ophthalmol; 2007 Oct; 245(10):1577-9. PubMed ID: 17458556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subconjunctival bevacizumab for corneal neovascularization.
    Doctor PP; Bhat PV; Foster CS
    Cornea; 2008 Oct; 27(9):992-5. PubMed ID: 18812760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival.
    Dastjerdi MH; Saban DR; Okanobo A; Nallasamy N; Sadrai Z; Chauhan SK; Hajrasouliha AR; Dana R
    Invest Ophthalmol Vis Sci; 2010 May; 51(5):2411-7. PubMed ID: 19892863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization.
    Koenig Y; Bock F; Horn F; Kruse F; Straub K; Cursiefen C
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1375-82. PubMed ID: 19415316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corneal graft surgery combined with subconjunctival bevacizumab (avastin).
    Symes RJ; Poole TR
    Cornea; 2010 Jun; 29(6):691-3. PubMed ID: 20458243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab.
    Dekaris I; Gabrić N; Drača N; Pauk-Gulić M; Miličić N
    Graefes Arch Clin Exp Ophthalmol; 2015 Feb; 253(2):287-94. PubMed ID: 25398659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab injection for corneal neovascularization refractory to bevacizumab treatment.
    Ahn YJ; Hwang HB; Chung SK
    Korean J Ophthalmol; 2014 Apr; 28(2):177-80. PubMed ID: 24688262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of superficial keratectomy and subconjunctival bevacizumab injection for corneal neovascularization.
    Qian CX; Bahar I; Levinger E; Rootman D
    Cornea; 2008 Oct; 27(9):1090-2. PubMed ID: 18812781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.
    You IC; Im SK; Lee SH; Yoon KC
    Cornea; 2011 Jan; 30(1):30-3. PubMed ID: 20861729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical bevacizumab for corneal neovascularization after penetrating keratoplasty.
    Saxena S; Kishore P; Pandey S; Khattri M; Kumar D
    Eur J Ophthalmol; 2009; 19(5):870-2. PubMed ID: 19787612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subconjunctival bevacizumab on corneal neovascularization: results of a prospective study.
    Benayoun Y; Adenis JP; Casse G; Forte R; Robert PY
    Cornea; 2012 Aug; 31(8):937-44. PubMed ID: 22357391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization.
    Yeung SN; Lichtinger A; Kim P; Amiran MD; Slomovic AR
    Cornea; 2011 Oct; 30(10):1110-4. PubMed ID: 21673570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.